ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026
Efficacy and safety of biologic therapies in immune checkpoint inhibitor-induced bullous pemphigoid.
Ghassan Barnawi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.